Evidence map›Paper›PMID 36500685›Full record

ArticleMolecules (Basel, Switzerland)2022

A Network-Pharmacology-Combined Integrated Pharmacokinetic Strategy to Investigate the Mechanism of Potential Liver Injury due to

Zhixin Jia, Lirong Liu, Cong Fang, Mingxia Pan, Shiyu Cong, Zhonghui Guo, Xiaoqin Yang, Jie Liu, Yueting Li, Hongbin Xiao

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Zhixin JiaBeijing Research Institute of Chinese Medicine, Beijing University of Chinese Medicine, Beijing 102401, China.ORCID 0000-0003-3849-2234
Lirong LiuResearch Center of Chinese Medicine Analysis and Transformation, Beijing University of Chinese Medicine, Beijing 102401, China.
Cong FangResearch Center of Chinese Medicine Analysis and Transformation, Beijing University of Chinese Medicine, Beijing 102401, China.
Mingxia PanResearch Center of Chinese Medicine Analysis and Transformation, Beijing University of Chinese Medicine, Beijing 102401, China.
Shiyu CongResearch Center of Chinese Medicine Analysis and Transformation, Beijing University of Chinese Medicine, Beijing 102401, China.ORCID 0000-0001-6100-7335
Zhonghui GuoResearch Center of Chinese Medicine Analysis and Transformation, Beijing University of Chinese Medicine, Beijing 102401, China.
Xiaoqin YangResearch Center of Chinese Medicine Analysis and Transformation, Beijing University of Chinese Medicine, Beijing 102401, China.
Jie LiuBeijing Research Institute of Chinese Medicine, Beijing University of Chinese Medicine, Beijing 102401, China.
Yueting LiResearch Center of Chinese Medicine Analysis and Transformation, Beijing University of Chinese Medicine, Beijing 102401, China.
Hongbin XiaoBeijing Research Institute of Chinese Medicine, Beijing University of Chinese Medicine, Beijing 102401, China.

Funding

Beijing Municipal Natural Science Foundation 7214284Fundamental Research Funds for the Central Universities 2020-JYB-ZDGG-105National Natural Science Foundation of China 81573839
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Fallopia multifloraPolygonumAnimalsGlucosidesLiverPhosphatidylinositol 3-KinasesRatsGlucosidesPhosphatidylinositol 3-Kinasesintegrated pharmacokineticsnetwork pharmacologyPolygonum multiflorum (PM)potential liver injury

Identifiers

PMID36500685
PMCPMC9740939

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.